TEL: +1 (415) 889 1010

US Capital Global Advises on $2 Million Convertible Note Investment in Toolbox Genomics

Toobox Genomics
Click the image to read the investment summary

San Francisco-based private financial group provides financial advisory services to expanding DNA testing company.

SAN FRANCISCO, November 2018 – US Capital Global is engaged as exclusive financial advisor on a $2 million convertible note investment in Toolbox Genomics, Inc., an emerging company in the genetic testing health field. Toolbox Genomics is dedicated to becoming the healthcare industry’s gold standard for turning individual DNA genetic testing results into scientifically-based, easy-to-understand, personalized lifestyle recommendations for actionable preventive care.

Headquartered in San Francisco, US Capital Global is a full-service private financial group with an established track record in investment banking and capital raise services. Its registered broker-dealer affiliate, US Capital Global Securities, LLC, is acting as the exclusive placement agent for this convertible note offering in Toolbox Genomics.

Didier Perez, CEO at Toolbox Genomics, said: “We are excited to be working with US Capital Global’s skilled advisory team as we move forward with our growth plans to bring to market actionable health recommendations based on a person’s individual DNA. With US Capital Global’s support and expertise, Toolbox Genomics is well-positioned to enhance its platform and pursue plans to go to market.”

“It is a pleasure serving Toolbox Genomics as its exclusive financial advisor,” said Charles Towle, Managing Partner at US Capital Global. “Our shared enthusiasm for Toolbox Genomics’ unique product was a key determinant in accepting this engagement. We believe the company is in a strong position to advance its strategic market expansion into the rapidly growing digital health sector. The opportunity to participate in Toolbox Genomics’ $2 million convertible note investment is now open to eligible investors.”

About Toolbox Genomics

Toolbox Genomics develops personalized, DNA-based products that provide licensed healthcare practitioners, nutritionists, dietician, and wellness professionals with actionable, evidence-based Health Action Plans™ focused on nutrition, supplements, and exercise. Learn more

About US Capital Global

Since 1998, the US Capital team has been committed to providing small and lower middle market businesses and investors with sophisticated debt, equity, and investment opportunities usually available only to larger middle market companies and institutional investors. The US Capital Global group manages direct investment funds and provides wealth management and capital raise services. Operating with its registered investment bank affiliate, US Capital Global Securities, LLC, the firm acts as a licensed placement agent for companies, funds, and projects, and collaborates closely with its peers in professional banking and investment advisory.

To learn more about US Capital Global Securities or this investment opportunity, email Charles Towle, CEO, at or call +1 415-889-1010.

Download a PDF of this Press Release